// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
USP Principal Scientific Liaison Margareth Marques, Ph.D., provides answers to questi
Many of the drug ingredients used in generic medicines around the world are produced in China, an
Validation and verification of analytical procedures are quality assurance activities with broad